Today

Agents

Chat

Arena

Discover

More

App

Pacira Biosciences: Oppenheimer cuts to perform from outperform

PCRX•2026-10-09

Oppenheimer cut its rating on Pacira Biosciences to perform from outperform.

Related News

P

PepsiCo: JPMorgan cuts target price to $137 from $138

PEP•2026-10-09

Enerflex Ltd.: CIBC raises target price to $32 from $30

EFXT•2026-10-09

Networking startup Eliyan draws takeover interest, held early talks with Arm

ARM•2026-10-09

Arbor Realty Trust: Piper Sandler cuts target price to $3.50 from $5

ABR•2026-10-09

Marcus & Millichap expands Brown & Brown preferred partner relationship into Canada

MMI•2026-10-08

Pacira Biosciences: Oppenheimer cuts to perform from outperform - PCRX News | Rallies